Program

HomeProgram ▶ Conference Faculty and Planners Disclosures
Conference Faculty and Planners Disclosures

In accordance with the ACCME Standards for Commercial Support, and those of the ATS Policy on Management of Conflict of Interest in Official ATS Documents, Projects and Conferences, ATS Policy Governing Relationships Between the Tobacco Industry, ATS Members, and Non-Members Who Participate in ATS Activities, and ATS Policy on Professionalism and Ethical Conduct chairs, moderators, presenters and official planners of the International Conference are required to disclose to ATS any potential conflicts of interest (COI) held by them or their spouse/life partner relevant to their presentation(s) or conference role, including all professional or other financial involvement with tobacco or e-cigarette entities, all relevant financial relationships with commercial interests, and all other relationships that could be perceived as influencing their participation. Conference presenters are also asked to disclose if there will be any discussion in the presentation of “off-label” (unapproved) use of substances/products not approved in the United States for the use under discussion (as per the U.S. Food and Drug Administration Guidance for Industry: Industry-Supported Scientific and Educational Activities).

For the 2017 International Conference, this disclosure information for all individuals in control of content was requested and received by ATS in advance of the Conference, reviewed by appropriate ATS reviewers, and session chairs and others in positions of authority were instructed to manage (resolve) identified faculty conflicts according to procedures overseen by the ATS Ethics and Conflict of Interest Committee.

Faculty Disclosures

To access the disclosures made by the faculty of the 2017 International Conference, please go to http://conference.thoracic.org/speakers.

Planners Disclosures

The following members of the Education Committee have disclosed no financial relationships with commercial interests:

Debra M. Boyer, MD, Chair
Jason T. Poston, MD, Vice Chair
Gaetane C. Michaud, MD, Vice Chair
Mark K. Abe, MD
Shozab Ahmed, MBBS
William G. Carlos, MD
Alison S. Clay, MD
Walter D. Conwell, MD
Daniel R. Crouch, MD, MS
DorAnne M. Donesky, PhD, ANP-BC
Garth Garrison, MD
David Gozal, MD, MBA
Margaret M. Hayes, MD
Amjad Horani, MD
Shazia M. Jamil, MD
Carl A. Kaplan, MD
Jack Kelly
Denay P. Kirkpatrick, DNP
Abagail R. Lara, MD
Moishe Liberman, MD, PhD
Andrew Luks, MD
Patrick Lyons, MD
Samir Makani, MD
Atul Malhotra, MD
Jakob I. McSparron, MD
Paul E. Moore, MD
Marc Moss, MD
Viswam S. Nair, MSCR, MD
Jeremy E. Orr, MD
Susan Pasnick, MD
Jessica E. Pittman, MD, MPH
Allan J. Walkey, MD, MSc
Tisha S. Wang, MD
Carolyn H. Welsh, MD
Lisa F. Wolfe, MD

The following members of the Education Committee have disclosed the following financial relationships with commercial interests:

Caralee E. Caplan-Shaw, MD: AristaMD and Cohero Health (Consultant); Bard Peripheral Vascular, Inc. and Veran Medical Technologies (Food/Beverage Only); Cook Incorporated (Food/ Beverage Only, Spouse-CME Speaker); MedImmune, Novartis Pharma and Teva Pharmaceuticals USA (Research Support); Myriad Genetic Laboratories (Spouse-Consultant)
Colleen L. Channick, MD: Actelion Pharmaceuticals US and Bayer HealthCare Pharmaceuticals (Spouse- Consultant); Medtronic and Olympus Corporation of the Americas (Consultant)
Charles Dela Cruz, MD, PhD: Cempra (Advisory Committee); Sanofi-Aventis U.S. (Consultant)
Samaan Rafeq, MD: Boston Scientific (Consultant, Speaker); Veran Medical (Consultant)
Jordan S. Rettig: Boston’s Children Hospital (Intellectual Property Not Commercialized)
Mary E. Strek, MD: Boehringer Ingelheim Pharmaceuticals (Data and Safety Monitoring Board, Research Support); Gilead Sciences, InterMune, MedImmune, and Vertex Pharmaceuticals (research support)
Bishoy Zakhary, MD: ELSO ECMO Training Courses and ACCP (Course Instructor)

The following members of the International Conference Committee have disclosed no financial relationships with commercial interests:

Zea Borok, MD, Chair
Jess Mandel, MD, Chair Appointee
JiYeon Choi, PhD, RN
Colin R. Cooke, MD
Sonye K. Danoff, MD, PhD
Laura C. Feemster, MSc, MD
Andrew P. Fontenot, MD
Michelle N. Gong, MD, MS
David Gozal, MD, MBA
Tillie-Louise Hackett, PhD
Anastassios C. Koumbourlis, MD, MPH
Patty Lee, MD
Tricia D. LeVan, PhD
Atul Malhotra, MD
William Man, MD, PhD
Paul E. Moore, MD
Marc Moss, MD
Marilyn Moy, MD, MSc
Robert L. Owens, MD
Karen M. Ridge, PhD
Jussi J. Saukkonen, MD
Gwen S. Skloot, MD
Christopher G. Slatore, MD
Anne I. Sperling, PhD
Renee D. Stapleton, PhD, MD
Lynn T. Tanoue, MD
Esra Tasali, MD
Judith Tate, PhD, RN

The following members of the International Conference Committee have disclosed the following financial relationships with commercial interests:

Anna Hemnes, MD: Actelion Pharmaceuticals, US and United Therapeutics Corporation (Advisory Committee); Pfizer, Inc. (Expert Testimony)
Tim Lahm, MD: Bayer HealthCare Pharmaceuticals (Speaker); Gilead Sciences and Pfizer AG (Research Support)
Augusto A. Litonjua, MD: AstraZeneca Pharmaceuticals (Advisory Committee); Springer Humana Press and UpToDate (author)
Mark L. Metersky, MD: Aradigm and Bayer (Research Support); EBSCO (Consultant); Grifols (Advisory Committee)
Frank C. Sciurba, MD: Boehringer Ingelheim b.v. (Advisory Committee); BTG and Pulmonx Corporation (Research Support)